GHK-Cu Capsules (3mg) 60 capsules GHK-Cu Oral Capsules: Gly-His-Lys copper(II) complex, 3mg/capsule × 60, ≥98% purity by HPLC TGF-β / NF-κB Pathway Research: ECM remodeling, NF-κB anti-inflammatory signaling studies Oral Pharmacokinetics Studies: GI bioavailability and SIRT1/STAT3 colitis-model research Manufacturer: RiboCore Availability: 100 in stock SKU: RP-GHK-3MG $84.00 Qty: Add to cart Ship to Select country United States of America Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia (Plurinational State of) Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cabo Verde Cambodia Cameroon Canada Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo (Democratic Republic of the) Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czechia Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Eswatini Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea (Democratic People's Republic of) Korea (Republic of) Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia (Federated States of) Moldova (Republic of) Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island North Macedonia Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela (Bolivarian Republic of) Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe * Other * Shipping Method Name Estimated Delivery Price No shipping options Apply Custom wishlist OK Add to wishlist Add to compare list Email a friend Technical Specifications CharacteristicValue CAS Number49557-75-7 Molecular Weight (Cu complex)403.92 Da Molecular Formula (Cu complex)C₁₄H₂₄CuN₆O₄ Purity≥98% (HPLC) FormOral capsules, 3mg per capsule, 60 capsules per bottle GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper(II)) is a naturally occurring tripeptide-copper complex first isolated from human plasma albumin in 1973 by Dr. Loren Pickart at UCSF. Intended strictly for qualified researchers as an investigational research compound, it has been the subject of over 100 peer-reviewed publications documenting extracellular matrix remodeling, anti-inflammatory signaling, antioxidant defense, and genome-wide gene-expression research. This oral capsule format (3mg × 60) is supplied for research into oral peptide pharmacokinetics, gastrointestinal bioavailability, and intestinal epithelial cell biology. Key Research Highlights Research AreaKey Finding Oral GI Colitis ModelOral gavage at 20 mg/kg in DSS-induced colitis mice: SIRT1/STAT3 pathway modulation, restored ZO-1/Occludin, suppressed TNF-α, IL-6, IL-1β (Mao et al., 2025) Genome-Wide Gene Modulation31.2% of human genes show ≥50% expression change; 47 DNA-repair genes and 16/18 antioxidant genes upregulated (Broad Institute CMap; Pickart & Margolina, 2018) Antioxidant Enzyme ResearchReduces ferritin iron release by 87%; direct scavenging of 4-HNE, acrolein, and MDA; Nrf2 pathway activation (Pickart et al., 2012) Research Applications Oral peptide pharmacokinetics and GI bioavailability NF-κB and SIRT1/STAT3 anti-inflammatory pathway research TGF-β signaling and ECM remodeling studies Nrf2 antioxidant pathway investigation Genome-wide transcriptomic profiling in aging-biology models Neuroprotection and neuroinflammation research Research Use Only. This product is supplied for in vitro laboratory investigation by qualified researchers. Not for human or veterinary consumption, diagnosis, treatment, prevention, or cure of any condition. Not approved by the FDA for human use.